Alphamanix
showed ability to reduce the proliferation of cancer cells. "One component has a small activity, but it is very marginal, smaller than that presented by conventional treatments." In a statement, the ministry said that the Alphamanix results are preliminary and that "there is still no conclusive report on the substance." Read too: Doctors can not prescribe "anti-cancer pill" defines Medical Council Anticancer pill: populism is bad for health Another worrying point, according to the researcher, was the fact that the capsules do not show the same amount of substance in each. While the label indicated that there should be 500 mg per capsule, 16 specimens weighed quantity ranged from 233 milligrams to 368 milligrams.
5 out of 5 from 1 reviews